Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health.

[1]  P. Yadav,et al.  A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women. , 2016, JAMA dermatology.

[2]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[3]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[4]  R. Ivell,et al.  Regulation of the reproductive cycle and early pregnancy by relaxin family peptides , 2014, Molecular and Cellular Endocrinology.

[5]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[6]  M. Cedars,et al.  Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. , 2013, Fertility and sterility.

[7]  Jon Wakefield,et al.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.

[8]  R. Norman,et al.  Hyperinsulinemia is common in family members of women with polycystic ovary syndrome. , 1996, Fertility and sterility.

[9]  D. Wilcken,et al.  A twin study of polycystic ovary syndrome and lipids. , 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[10]  S. Franks,et al.  Evidence for a single gene effect causing polycystic ovaries and male pattern baldness , 1993 .

[11]  Xiaohui Xie,et al.  Identifying novel constrained elements by exploiting biased substitution patterns , 2009, Bioinform..

[12]  Bjarni V. Halldórsson,et al.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome , 2015, Nature Communications.

[13]  T. Key,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .

[14]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[15]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[16]  C. Dray,et al.  LRP1 Receptor Controls Adipogenesis and Is Up-Regulated In Human and Mouse Obese Adipose Tissue , 2009, PloS one.

[17]  D. Gaudet,et al.  Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway , 2009, Clinical genetics.

[18]  Zoltán Kutalik,et al.  Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.

[19]  Zhou Wang,et al.  Identification and characterization of PLZF as a prostatic androgen‐responsive gene , 2004, The Prostate.

[20]  N. Sheehan,et al.  Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.

[21]  Dolian Gg,et al.  Diagnostic criteria for polycystic ovary syndrome , 1989 .

[22]  M. McCarthy,et al.  Prevalence of polycystic ovaries in women with androgenic alopecia. , 2003, European journal of endocrinology.

[23]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[24]  Enrico Carmina,et al.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.

[25]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[26]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[27]  Stuart J. Ritchie,et al.  Genetic prediction of male pattern baldness , 2016, bioRxiv.

[28]  Tatiana A. Tatusova,et al.  Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..

[29]  D. Boomsma,et al.  0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(6):2100–2104 Printed in U.S.A. Copyright © 2006 by The Endocrine Society doi: 10.1210/jc.2005-1494 Heritability of Polycystic Ovary Syndrome in a Dutch Twin-Family Study , 2022 .

[30]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[31]  Jake K. Byrnes,et al.  Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.

[32]  M. McCarthy,et al.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations , 2015, Nature Communications.

[33]  S. Tevosian,et al.  The transcription factor GATA4 is required for follicular development and normal ovarian function. , 2013, Developmental biology.

[34]  U. Thorsteinsdóttir,et al.  Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. , 2012, The Journal of clinical endocrinology and metabolism.

[35]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[36]  R. Clayton,et al.  Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. , 1999, The Journal of clinical endocrinology and metabolism.

[37]  Claude Bouchard,et al.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.

[38]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[39]  R. Azziz,et al.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. , 2013, Journal of Clinical Endocrinology and Metabolism.

[40]  R. Williamson,et al.  Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. , 1993, Clinical endocrinology.

[41]  P. Claman.  Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[42]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[43]  Jianhua Ruan,et al.  The regulatory repertoire of PLZF and SALL4 in undifferentiated spermatogonia , 2016, Development.

[44]  P. Pandolfi,et al.  Promyelocytic Leukemia Zinc Finger Protein Activates GATA4 Transcription and Mediates Cardiac Hypertrophic Signaling from Angiotensin II Receptor 2 , 2012, PloS one.

[45]  J. Gris,et al.  Identification of Patients with Impaired Hepatic Drug Metabolism Using a Limited Sampling Procedure for Estimation of Phenazone (Antipyrine) Pharmacokinetic Parameters , 1993, Clinical pharmacokinetics.

[46]  B. Zhang,et al.  Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 , 2011, Nature Genetics.

[47]  Olena O Yavorska,et al.  MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.

[48]  E. Diamanti-Kandarakis,et al.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. , 2012, Endocrine reviews.

[49]  R. Norman,et al.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. , 2010, Human reproduction.

[50]  Yuhua Shi,et al.  Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome , 2012, Nature Genetics.

[51]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[52]  Andrew D. Johnson,et al.  Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche , 2014, Nature.

[53]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[54]  Ian M. Fingerman,et al.  Database resources of the National Center for Biotechnology Information , 2010, Nucleic Acids Res..

[55]  D. Driscoll,et al.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  O. Cummings,et al.  Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. , 2010, Gastroenterology.

[57]  M. Järvelin,et al.  Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study. , 2012, Human reproduction.

[58]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[59]  M. Pepper,et al.  Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation. , 2016, Stem cell research.

[60]  J. Manson,et al.  Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. , 2001, JAMA.

[61]  Christopher T. Saunders,et al.  Evaluation of structural and evolutionary contributions to deleterious mutation prediction. , 2002, Journal of molecular biology.

[62]  S. Jahanfar,et al.  A twin study of polycystic ovary syndrome. , 1995, Fertility and sterility.

[63]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[64]  Tim D Spector,et al.  The UK Adult Twin Registry (TwinsUK) , 2006, Twin Research and Human Genetics.

[65]  R. Azziz,et al.  Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. , 2001, Fertility and sterility.

[66]  B. Yıldız,et al.  Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. , 2012, Human reproduction.

[67]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[68]  L. Liang,et al.  A comprehensive survey of genetic variation in 20 , 691 subjects from four large cohorts 1 , 2016 .

[69]  J. Lawler,et al.  Thrombospondin‐1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor‐related protein‐1 (LRP‐1) , 2007, Journal of cellular physiology.

[70]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[71]  Thomas L. Madden,et al.  Database resources of the National Center for Biotechnology Information. , 2019, Nucleic acids research.

[72]  L. Liang,et al.  Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index. , 2016, Human molecular genetics.

[73]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[74]  M. Sammel,et al.  High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis , 2017, Human reproduction.

[75]  F. Azizi,et al.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study , 2011, Reproductive biology and endocrinology : RB&E.

[76]  R. Lanz,et al.  The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization , 2016, PLoS genetics.